Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The Record History now includes options to 'Check who can join' and 'Find Contact Information', and it shows Revision: v3.6.0 while removing the previous Revision: v3.5.5.
    Difference
    0.6%
    Check dated 2026-06-12T16:51:30.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The record history now lists a new revision entry for v3.5.5. The previous revision v3.5.4 has been removed from the history display.
    Difference
    0.1%
    Check dated 2026-06-05T17:53:25.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the Record History, replacing v3.5.3 and signaling a newer version of the record.
    Difference
    0.1%
    Check dated 2026-05-15T07:45:47.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision indicator updates from v3.5.2 to v3.5.3, reflecting a change in the site’s current software version rather than the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:12.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; Deleted revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:27.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:32.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.